EGFR and adenocarcinoma: EGFR+/TATI+ correlated with histology occurring more often in adenocarcinomas than in other histological tumour types (p = 0.005), and varied by WHO grade, being most often present in highly and moderately differentiated tumours (p<0.001)(Table 2).